Aikido Stock Analysis


USD 6.85  0.15  2.14%   

The current bullish price patterns experienced by current Aikido Pharma shareholders could raise concerns from stockholders as the firm is trading at a share price of 6.85 on 49,200 in volume. The company management teams have been very successful in rebalancing the firm assets at opportune times to take advantage of market volatility in August. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.04. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Aikido Pharma partners.
Please continue to Trending Equities.
The Aikido Pharma stock analysis report makes it easy to digest most publicly released information about Aikido Pharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Aikido Stock analysis module also helps to analyze the Aikido Pharma price relationship with some important fundamental indicators such as market cap and management efficiency.

Aikido Stock Analysis Notes

The company recorded a loss per share of 0.07. Aikido Pharma last dividend was issued on the 12th of May 1980. The entity had a split on the 28th of October 2019. AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York. Aikido Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Aikido Pharma please contact the company at 703 992 9325 or go to

Aikido Pharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aikido Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aikido Pharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aikido Pharma has very high historical volatility over the last 90 days
Aikido Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9 K. Net Loss for the year was (9.75 M) with profit before overhead, payroll, taxes, and interest of 9 K.
Aikido Pharma currently holds about 68.57 M in cash with (9.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from MacroaxisInsider: Purchase by Wool Kyle Michael of 3559 shares of Aikido Pharma

Aikido Pharma Upcoming and Recent Events

Earnings reports are used by Aikido Pharma to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aikido Pharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of March 2022
Next Financial Report10th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Aikido Pharma SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Aikido Pharma prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Aikido Pharma investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Aikido Pharma specific information freely available to individual and institutional investors to make a timely investment decision.
9th of September 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
19th of August 2022
Other Events
6th of July 2022
Financial Statements and Exhibits. Changes in Registrant's Certifying Accountant
28th of June 2022
Financial Statements and Exhibits. Other Events
14th of June 2022
Unclassified Corporate Event
10th of June 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
25th of May 2022
Submission of Matters to a Vote of Security Holders
30th of March 2022
Other Events

Aikido Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aikido Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aikido Pharma backward and forwards among themselves. Aikido Pharma's institutional investor refers to the entity that pools money to purchase Aikido Pharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares216.2 K1.3 M
Blackrock IncCommon Shares75.3 K444 K
Equitec Proprietary Markets LlcCommon Shares63.3 K373 K
Dimensional Fund Advisors LpCommon Shares45.7 K269 K
Geode Capital Management LlcCommon Shares43.1 K253 K
Renaissance Technologies LlcCommon Shares30.7 K181 K
State Street CorpCommon Shares20 K118 K
Note, although Aikido Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aikido Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 619.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aikido Pharma's market, we take the total number of its shares issued and multiply it by Aikido Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (6.13) % which means that it has lost $6.13 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (6.09) %, meaning that it created substantial loss on money invested by shareholders. Aikido Pharma management efficiency ratios could be used to measure how well aikido pharma manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 25th of September, Aikido Pharma shows the Risk Adjusted Performance of 0.1244, downside deviation of 3.04, and Mean Deviation of 2.26. Aikido Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect data for nineteen technical drivers for Aikido Pharma, which can be compared to its rivals. Please confirm Aikido Pharma variance, as well as the relationship between the maximum drawdown and semi variance to decide if Aikido Pharma is priced correctly, providing market reflects its regular price of 6.85 per share. Given that Aikido Pharma has jensen alpha of 0.3518, we suggest you to validate Aikido Pharma's prevailing market performance to make sure the company can sustain itself at a future point.

Aikido Pharma Price Movement Analysis

The output start index for this execution was three with a total number of output elements of fifty-eight. The Moving Average is predictive technique used to analyze Aikido Pharma price data points by creating a series of averages of different subsets of Aikido Pharma entire price series.

Aikido Pharma Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aikido Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aikido Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aikido Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aikido Pharma Predictive Daily Indicators

Aikido Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aikido Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aikido Pharma Forecast Models

Aikido Pharma time-series forecasting models is one of many Aikido Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aikido Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Aikido Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aikido Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aikido shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Aikido Pharma. By using and applying Aikido Stock analysis, traders can create a robust methodology for identifying Aikido entry and exit points for their positions.
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York. Aikido Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Current Aikido Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aikido analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aikido analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
2.0Strong Buy1Odds
Aikido Pharma current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aikido analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aikido stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aikido Pharma, talking to its executives and customers, or listening to Aikido conference calls.
Aikido Analyst Advice Details

Aikido Stock Analysis Indicators

Aikido Pharma stock analysis indicators help investors evaluate how Aikido Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aikido Pharma shares will generate the highest return on investment. By understating and applying Aikido Pharma stock analysis, traders can identify Aikido Pharma position entry and exit signals to maximize returns.
Shares Percent Shares Out1.28%
Quick Ratio76.61
Fifty Two Week Low4.30
Short Percent Of Float1.29%
Forward Price Earnings-3.13
Float Shares5.03M
Fifty Two Week High16.66
Shares Short Prior Month59.89k
Average Daily Volume Last 10 Day277.79k
Average Daily Volume In Three Month92.62k
Fifty Day Average6.08
Two Hundred Day Average7.13
Please continue to Trending Equities. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for analysis

When running Aikido Pharma price analysis, check to measure Aikido Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aikido Pharma is operating at the current time. Most of Aikido Pharma's value examination focuses on studying past and present price action to predict the probability of Aikido Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aikido Pharma's price. Additionally, you may evaluate how the addition of Aikido Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Is Aikido Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aikido Pharma. If investors know Aikido will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aikido Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aikido Pharma is measured differently than its book value, which is the value of Aikido that is recorded on the company's balance sheet. Investors also form their own opinion of Aikido Pharma's value that differs from its market value or its book value, called intrinsic value, which is Aikido Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aikido Pharma's market value can be influenced by many factors that don't directly affect Aikido Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aikido Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Aikido Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aikido Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.